• Explore /
  • Poster
  • / CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.

CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.

Abstract Video & Slides Poster

Authors

null

Peter Kar Han Lau

Peter MacCallum Cancer Centre, Sir Charles Gairdner Hospital, Harry Perkins Institute for Medical Research, University of Western Australia, Melbourne, Australia

Peter Kar Han Lau , Samuel John Harris , Melissa A. Eastgate , Damien Kee , Andrew Mant , Louise M. Nott , Craig Gedye , Andrisha Jade Inderjeeth , Craig Underhill , Alison Margaret Weppler , Roslyn Wallace , Belinda Lee , George Au-Yeung , Narelle Williams , Daniel Ariza Ospino , Louise Gonzales , Mark J. Shackleton , Serigne N. Lo , Grant A. McArthur , Shahneen Sandhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03161756

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9525)

DOI

10.1200/JCO.2023.41.16_suppl.9525

Abstract #

9525

Poster Bd #

288

Abstract Disclosures

Similar Posters

First Author: Yousef Zakharia

First Author: Celeste Lebbe

First Author: Maria Constantinou

First Author: Howard Kaufman